Cancers, Vol. 13, Pages 4819: Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer

In conclusion, there were significant differences in the galectin levels in patients with these cancers compared with healthy controls, and galectin levels did not significantly change from stage to stage. These findings suggest that further research on the roles of galectins early in disease pathogenesis may lead to novel indications for galectin inhibitors.

Source: Cancers - September 26, 2021 Category: Cancer & Oncology Authors: Bailey B. Blair Avery T. Funkhouser Jane L. Goodwin Alexander M. Strigenz Basil H. Chaballout Julie C. Martin Connie M. Arthur Christopher Ronald Funk William Jeffery Edenfield Anna V. Blenda Tags: Article Source Type: research